METARAMINOL BITARTRATE (METARAMINOL BITARTRATE) — FDA Approval ANDA211304 (AZURITY)
METARAMINOL BITARTRATE (METARAMINOL BITARTRATE) — FDA Approval ANDA211304 (AZURITY) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: METARAMINOL BITARTRATE; Active ingredients: METARAMINOL BITARTRATE; Application number: ANDA211304.
| Brand name | METARAMINOL BITARTRATE |
|---|---|
| Active ingredients | METARAMINOL BITARTRATE |
| Application number | ANDA211304 |
| Sponsor | AZURITY |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20210824 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →